Should Malaysia consider introducing dengue vaccine into routine immunization programs?

Conflict of interest statement

The author declares that there are no conflicts of interest.

Funding

The authors received no extramural funding for the study.

Publisher’s note

The Publisher of the Journal remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Edited by Zhang Q, Lei Y, Pan Y

References

[1] International Federation of Red Cross and Red Crescent Societies. Malaysia: Dengue prevention and control. IFRC. 2024 Feb 15. [Online]. Available from: https://reliefweb.int/report/malaysia/malaysia-dengue-prevention-and-control-dref-operational-update-mdrmy010. [Accessed on 2 April 2025].

[2] Daniels BC, Ferguson N, Dorigatti I. Efficacy, public health impact, and optimal use of the Takeda dengue vaccine. medRxiv 2024; doi:https://doi.org/10.1101/2024.08.10.24311393

[3] Sahu MC, Samantaray RK, Pal A, Pati S. Recent advances on pathogenesis, diagnosis, prevention, immunological aspects, and vectors of dengue: A review. Asian Pac J Trop Biomed 2023; 13(8): 325-338.

[4] Biswal S, Reynales H, Saez-Llorens X, Lopez P, Borja-Tabora C, Kosalaraksa P, et al. Efficacy of a tetravalent dengue vaccine in healthy children and adolescents. New Engl J Med 2019; 381(21): 2009-2019.

[5] Nitika N, Bharti PK. TAK 003 dengue vaccine: A promising tool for dengue control. Asian Pac J Trop Med 2024; 17(11): 477-478.

[6] Pimentel C. Brazil to prioritize dengue vaccination for 6 to 16-year-olds. Agencia Brasil.2024 Jan 16. [Online]. Available from: https://agenciabrasil.ebc.com.br/en/saude/noticia/2024-01/brazil-prioritize-dengue-vaccination-6-16-year-olds. [Accessed on 2 April 2025].

[7] RT Staff Reporters.Low dengue vaccine uptake in Brazil amid government mistrust. The Rio Times. 2024 March 7. [Online]. Available from: Accessed on 2 April 2025].

[8] World Health Organization. WHO position on dengue vaccines- May 2024. [Online]. Available from: Accessed on 2 April 2025].